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INTRODUCTION 
There are probably at least five, genetically distinct isozymes of carbonic anhy- 
drase present in mammals (for discussion see refs. 1-3). It is of course tempting to 
speculate that each of these isozymes has a special function in the particular cells 
where they are expressed. However, before we can ascertain such specific cellu- 
lar or subcellular roles, we must first begin to identify more precisely the cellular 
localizations of the different isozymes. Utilizing immunohistochemical, or differ- 
ential inhibition techniques, the histochemists have already made some good 
progress toward assigning specific isozymes to various cells and tissues (e .g . ,  see 
some of the reports in this volume,”’ and TABLE 1). 
Considerable information has already been obtained concerning the physiolog- 
ical functions of carbonic anhydrase by studying the effects produced by the 
specific inhibition of carbonic anhydrase activity by aromatic or heterocyclic 
sulfonamides. For example, findings that the treatment of mammals with carbonic 
anhydrase inhibitors such as acetazolamide resulted in alterations in kidney func- 
tion (bicarbonate reabsorption) and gastric acid secretion suggested some time 
ago that carbonic anhydrase was probably present in renal tubular cells and cells 
of the gastric mucosa (see ref. 12 for review). However, since both carbonic 
anhydrase isozymes, CA I and CA 11, of mammals are strongly inhibited by 
sulfonamides, it was not possible to tell which isozyme(s) was present in the renal 
and gastric cells. 
a This work was supported by United States Public Health Service grants GM 24681 (to 
R.E.T.), GM 31988 and GM 210% (to W.S.S.) and HL 19737 (to R.E.F.). 
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Another potentially useful approach to this problem would be to study the 
physiological effects produced in individuals where a genetic leison has resulted 
in a deficiency in one of the isozymes. In this report, we will discuss the effects of 
two mutations in humans that have resulted in the virtual absence of either CA I 
or CA I1 in the erythrocytes of individuals who are homozygous for the defective 
carbonic anhydrase gene. 
CELLULAR AND TISSUE DISTRIBUTION 
In order to determine the potential defects that might be produced by a carbonic 
anhydrase deficiency, it is essential to learn something about the tissue and cellu- 
lar distribution of the carbonic anhydrase isozymes in humans and other mam- 
mals. In TABLE 1 are listed 14 tissues, organs or cells of mammals where one or 
more of the carbonic anhydrase isozymes has been identified either by immuno- 
histochemical means or by actual purification. As can be seen, the CA I1 or CA 
11-like isozymes are found in almost all of the listed tissues and organs, whereas 
the CA I and CA I11 isozymes appear to have a somewhat more limited distribu- 
tion. The apparent absence of CA I or CA 111 in some tissues should be viewed 
with caution, however, since these isozymes might be expressed (possibly at high 
levels) in only a small population of cells in a particular tissue and may have gone 
undetected by the technique employed. For the most part, the membrane- 
bound11-16 and mi toch~ndr i a l ' ~ -~~  carbonic anhydrases have not as yet been exten- 
sively characterized; nevertheless, in some it appears that they are 
the products of genetic loci distinct from those coding for the CA I, CA 11, and CA 
111 isozymes. At this stage in our knowledge of the distribution of the carbonic 
anhydrase isozymes, it is especially important to utilize both activity and immu- 
nological methods on the same tissue or cellular samples in order to gain insights 
on the localization of those isozymes (e.g., membrane-bound forms) for which 
antisera are not yet available. 
Although the physiological roles of the carbonic anhydrases in such tissues 
and cells as erythrocytes, the secretory epithelium of the stomach, and the lumi- 
nal cells of the kidney tubules are understood to some extent, the function of 
carbonic anhydrase is not as well understood in cells from such organs or tissues 
as brain, lung, colon, eye, bone, muscle, and liver. 
As already stated, an inherited deficiency in any one of the carbonic anhydrase 
isozymes could present us with a unique opportunity to examine the possible 
physiological role or roles of a particular isozyme. For example, if the CA I, CA 
11, and CA I11 isozymes in different tissues are each the products of single, 
separate loci, then one would predict that a defect in one of these genes might 
produce a defect in all of the cells in which that isozyme is normally expressed. 
DEFICIENCY OF CARBONIC ANHYDRASE I 
A deficiency of red cell CA I was described in a family originating from the Greek 
Island of Icaria.*O In this family, the individuals homozygous for the deficiency 
gene were asymptomatic. The hematological parameters and levels of CA I1 in the 
CA I-deficient red cells were within normal limits.2' The apparent lack of clinical 
abnormalities was not entirely unexpected, however, as it had been previously 
observed that the virtual absence of CA I from the red cells of pigtail macaques 
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TABLE 1. Distribution of Soluble Carbonic Anhydrase Isozymes (Identified by 
Immunohistochemical or Purification Procedures) in Selected Tissues and Cells 
of Humans and Other Mammals"  
lsozyme 
Source CA I CA I1 CA I11 
Kidney 
Proximal & distal tubules & collecting tubules: luminal epi- 
Renal medulla: purified from homogenate (human)% 
Osteoclasts (rat)'l 
Calcifying cartilage: extracellular matrix (rat)57 
Oligodendrocytes (human)58 
Astrocytes (mouse, rat)9J1.59 
Choroid plexus epithelium (rat)61 
Tracheobronchial glands: serous acini (human)" 
* Pulmonary artery endothelium ( 0 x 1 ~ ~  
Intra- & interlobular ducts: epithelium (human)63 
Submandibular & sublingual glands: striated duct cells (rat, 
thelium (human)s." 
Bone and Cartilage 
Brain 






Secretory coil: myoepithelial cells (human)6s 
Coiled & straight segment of duct: luminal & basal cells 
Secretory coil: clear cells (humanP 
Homogenate: immunochemical quantitation (human)@ 
Purified from homogenate (male rat)67 
Appendix: epithelium (hurnanP 
Gastric glands: parietal cells (human)68 
Gastric mucosa: parietal & foveola cells 
Gastric mucosa epithelium: purified from homogenate 
Epithelial cells of small intestine, caecum & proximal colon: 
Colon: superficial, non-goblet columnar cells (human)s." 
Rumen epithelium: basal, spinosum & granulosum layers 
Rumen epithelium: purified from homogenate ( 0 x 1 ~ ~  
Retina: Muller cells (h~rnanY. ' .~~ 
Lens: immunochemical quantitation ( h ~ m a n ) ~ ~ . ~ ~  
Ciliary process: epithelium (human)74 
Corneal endothelium (human)73 
Red skeletal muscle: purified from homogenate 









Capillary endothelium (rat)77 
Purified from homogenate (rat)18 
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CA I CA I1 CA Il l  
Adipose cells 
- Peribronchial fat cells (mouse)@ + 4- 
White fat cells: radioimmunoassay (rat)B - - 
Purified from hemolysate (human)"." + + + 
+ 
Erythrocytes 
Non-human species included only when no definitive information was available for that 
particular tissue or cell type in humans. Isozyme detected (+), isozyme not detected or trace 
levels attributed to red cell contamination (0), not tested (-). 
Although the vascular endothelium can be classified as a separate organ (cf. ref. 80) it 
has been listed under the different organs or tissues because of the likelihood that its 
function could vary somewhat depending on the tissue in which the blood vessel is located. 
(Mucacu nemestrina) that were homozygous for a CA I deficiency gene, was 
seemingly without any obvious e f f e ~ t . ~ ~ J ~  
Thus, although CA I or CA I-like isozymes have been identified from mamma- 
lian gastrointestinal mucosae, corneal endothelia, sweat glands, salivary glands, 
adipose cells, capillary endothelia, pituitary glands, and erythrocytes (TABLE l), 
it has not been possible as yet to determine whether CA I is also deficient in cells, 
other than erythrocytes, of CA I-deficient individuals. Nevertheless, preliminary 
studies utilizing fluorescent antibody techniques have shown that cultured lym- 
phocytes from CA I-deficient humans fluoresce as intensely as those from normal 
individuals (Tashian, unpublished work)," suggesting that the deficiency of CA I 
in mature red cells may be due to the rapid degradation of a labile CA I or its 
mRNA during erythropoiesis, whereas this degradation may not be as severe in 
cells with different kinds or levels of proteolytic enzymes or r ibonu~ leases .~~  This
possibility must, of course, await further analyses utilizing such quantitative tech- 
niques as the hybridization of CA I-mRNA with labeled CA I-cDNA probes. 
The red cell CA I/CA I1 ratios were tested in the individuals from the CA I- 
deficient family" shown in FIGURE 1. The CA I/CA I1 values for the obligate 
heterozygotes of 2.9 and 3.8 are about half those from normal individuals (FIG. 2). 
In a survey made of red cell CA I concentrations in 3376 individuals in a Japanese 
population, Goriki et a1.26 found 25 individuals with about half the normal CA I 
levels (ie., 5.5 2 0.6 mg/g Hb). If these individuals are heterozygous for a CA I 
deficiency gene, then the frequency of this gene in this population would be 
0.37%. No homozygous CA I-deficient individuals were detected. 
DEFICIENCY OF CARBONIC ANHYDRASE I1 
Since what appears to be the same CA I1 isozyme has now been reported from 
many tissues (TABLE l),  it would be expected that if these isozymes are the 
products of the same gene, that a mutation producing a defect in its expression 
might have wide-ranging physiological consequences. 
An inherited deficiency of red cell C A  I1 in humans has recently been reported 
where individuals homozygous for the deficiency gene are afflicted with a syn- 
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“1 losteopetrosis 
FIGURE 2. Histogram of individ- 
uals classified as normal (CA II ‘ICA 
I I + ) ,  or as heterozygous (CA II+ICA 
I I - )  or homozygous (CA II-ICA I I - )  
for CA I1 deficiency genes (CA ZZ-) 
on the basis of red cell CA IICA 11 
ratios as determined by HPLC (cf. 
refs. 27 and 29). Normals contain 
both controls and potential heterozy- 
gotes. 
addition to the family from the United States which is of German and Italian 
a n ~ e s t r y , ~ ’ . ~ ~  10 additional families have now been similarly diagnosed. The pedi- 
grees of these families are shown in FIGURE 1. Three of the families are from the 
United States (two of which are of Hispanic ancestry and the other of Northern 
European ancestry), one is from Belgium, and six are of Arabian ancestry from 
North Africa, Saudi Arabia, and Kuwait. All but one of the Arabian families 
are the result of first cousin marriages; and in all probability, each parent carries 
the same CA I1 deficiency gene. Although osteopetrosis was found in all of the 
homozygous, CA 11-deficient individuals, the severity of the renal tubular acido- 
sis and degree of cerebral calcification were found to vary28 (W. S. Sly and M. P. 
Whyte, unpublished results). 
The CA I/CA I1 ratios were determined by high performance liquid chroma- 
tography (HPLC).27,29 It was found that the obligate heterozygotes have values 
ranging from 11.5 to 18.8, which are about twice the values from the presumed 
normal, unaffected controls of 5.0 to 7.6. The values for the CA 11-deficient red 
cells of >lo4 represent minimal values. Since no CA I1 peaks could be detected by 
HPLC, the CA 1 levels were divided by the lowest measurable peaks in the elution 
patterns. The CA I/CA I1 values for the members of the families shown in FIGURE 
1, as well as those of the family from St. Louis originally described with the CA I1 
deficiency syndrome,*’ plus unaffected related and unrelated controls, are sum- 
marized in the histogram depicted in FIGURE 2. The lack of overlapping values 
between the normals and heterozygotes indicates that the CA I/CA I1 ratios can 
be used with reasonable confidence to detect carriers of the CA I1 deficiency gene. 
For comparative purposes, both presumed and obligate heterozygotes are deline- 
ated in FIGURE 2. 
The frequency of a CA I1 deficiency gene appears to be quite low in the 
Japanese population. In blood samples from 3292 Japanese individuals, presumed 
heterozygotes for a CA I1 deficiency gene were detected in only two cases (Goriki 
et a1.26). 
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THE CA 11 DEFICIENCY SYNDROME 
Bone Metabolism 
Since sulfonamide inhibition of carbonic anhydrase has been reported to inter- 
fere with bone r e s o ~ p t i o n , ~ ~ . ~ '  it was suggested that carbonic anhydrase, mediated 
through parathyroid hormone (FTH), in bone cells may play an important role in 
bone r n e t a b ~ l i s m . ~ ~ - ~ ~  There is also histochemical evidence for the presence of CA 
I1 in rat o s t e o ~ l a s t s . ~ ~  However, it was not until the findings that CA I1 deficiency 
is associated with an  impairment of bone resorptionz7 that a physiological role for 
CA I1 was specifically implicated in osteoclasts. 
Renal Tubular Acidosis 
The renal tubular acidosis that has been reported for some of the CA I1 defi- 
cient individuals seems to have both a proximal and distal component.38 Since CA 
I1 is probably the major soluble isozyme of carbonic anhydrase in the human 
kidney,39 and specifically in the luminal cells of the proximal and distal tubules, as 
indicated by histochemical studies,40 then the absence or reduction of this iso- 
zyme in the luminal cells might be expected to interfere with bicarbonate reab- 
sorption and hydrogen ion secretion, producing the "mixed" type of renal tubular 
acidosis reported in some CA 11-deficient  individual^.^^ 
Another feature of interest is that we have learned something about the nature 
of the membrane-bound form of carbonic anhydrase, which has been described 
from the brush border and basolateral membrane of the luminal cells of the renal 
tubules in humans.'"I6 Whether or not this bound carbonic anhydrase is CA I1 or 
a genetically distinct isozyme of carbonic anhydrase has been clarified somewhat 
by the finding that diuresis could be induced in two homozygous CA 11-deficient 
members of the St. Louis familyz7 after treatment with acetazolamide (W. S. Sly 
and M. P. Whyte, unpublished results). This finding suggests that the bound 
carbonic anhydrase is normal in the CA II-deficient individuals and that the 
uptake of H2CO3 is not impaired in the luminal cells. However, the reabsorption 
of HCO? is defective because of the presumed lack of soluble CA I1 in the luminal 
cells. 
Cerebral Calcification 
From histochemical analyses of mammalian brain tissue, carbonic anhydrase 
has been reported in oligodendrocytes, astrocytes, and choroid plexus epithelium 
(see TABLE l ) ,  and it appears that in all cases this is the high-activity CA I1 
isozyme. However, 50-60% of the carbonic anhydrase in rat brain homogenates is 
membrane b o ~ n d . ~ ' * ~ ~  The interesting feature here is that even though the bound 
and soluble forms have similar molecular weights, and activities similar to the 
high-activity CA I1 isozyme of erythrocytes, they appear to be immunologically 
distinct from CA I1 and are synthesized on different polyribosomal complexes,43 
suggesting that they may be products of different genes. It would, therefore, be 
extremely interesting to determine if one, both, or none of these CA 11-like forms 
are absent or diminished in individuals who are homozygous for the CA I1 defi- 
ciency gene. 
The basis for the cerebral calcification as well as the mental retardation in the 
CA 11-deficient individuals remains an enigma. Although mental retardation in 
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these individuals appears to be associated with some level of cerebral calcifica- 
tion, the opposite is not always true. That is, some CA 11-deficient individuals 
whose intelligence was classified as “low normal” exhibited progressive (dense) 
basal ganglia1 calcification.28 Furthermore, none of the affected individuals in one 
family with inherited calcification of basal ganglia exhibited any evidence of men- 
tal retardation, osteopetrosis, or renal tubular acidosis.* Carbonic anhydrase 
levels were not tested in the red cells of the affected individuals. 
Basal ganglion calcification most often occurs in hyp~parathyroidism.~~,~~ In 
the St. Louis family with CA I1 deficiency and osteopetrosis, the levels of FTH for 
all three affected sisters were reported to be in the normal rangeZ8 and could 
therefore be classified as p~eudohypoparathyroidism.~~ It thus appears to be most 
likely that the CA I1 deficiency in certain brain cells prevents the normal metabo- 
lism of calcium in these cells resulting in the calcification of certain areas of the 
brain. 
VARIABLE EFFECT OF THE CA I1 DEFICIENCY 
Why is there no apparent outward effect of the CA I1 deficiency in tissues other 
than bone, kidney, and brain where a high-activity CA 11-like isozyme has been 
identified (see TABLE l)? There are several possible explanations for this puzzling 
situation. First, alternative physiological mechanisms could substitute for the 
normal CA I1 function. Second, the mutation could render the CA I1 or its mRNA 
more labile to degradation, and the levels of CA I1 could vary from tissue to tissue 
where it is normally expressed depending on the turnover of CA 11, or the type of 
proteolytic enzymeZS or ribonuclease present in a particular cell type. Third, there 
may be two or more CA I-like or CA 11-like isozymes that are very similar or 
identical in structure but coded for by separate, closely linked genes that are 
differentially expressed in the cells of various tissues. Possible evidence for more 
than one CA I1 gene in the mouse has been discussed by Venta et al.3 
As an extention of the first explanation given above, there is always the 
possibility that if both CA I and CA I1 are normally present in a particular cell, 
such as the red cell, CA I can take over the role of CA 11. Although this may be the 
case for erythrocytes, as will be discussed next, it would be surprising if CA I 
could fulfill the function of CA I1 in all of the tissues where both isozymes are 
expressed. 
The tissues of the eye are known to contain the CA I1 isozyme almost exclu- 
sively (see TABLE 1). Since serious clinical abnormalities of the eye have not been 
reported in CA 11-deficient individuals, it was of interest to learn something about 
the levels of CA I1 in the eyes of an affected individual. The carbonic anhydrase 
inhibitor, acetazolamide (Diamox), is known to reduce intraocular p r e s ~ u r e , ~ * , ~ ~  
and if CA I1 is absent or diminished in the cells of ocular tissues, one would expect 
no change in intraocular pressure with Diamox treatment. Two affected adults 
from the St. Louis family with the CA I1 deficiency geneZ7 were treated with 
Diamox and no change in intraocular pressure was detected (W. S. Sly, M. P. 
Whyte, and T. Krupin, unpublished results). These preliminary findings suggest 
that CA I1 may also be deficient in the eyes of these individuals. 
The findings some years ago by Maren and his colleagues (see ref. 12 for 
review) that the treatment of dogs with high doses of carbonic anhydrase inhibi- 
tors for extensive periods of time did not produce any serious developmental or 
physiological abnormalities contrasts with the findings of clinical abnormalities 
reported in the CA 11-deficient  human^.^^.*^ One possible explanation is that the 
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carbonic anhydrase inhibitors did not completely inhibit carbonic anhydrase ac- 
tivity, and that the residual activity was sufficient to maintain the normal func- 
tional and developmental roles of the carbonic anhydrases. On the other hand, 
Maren's early animal studies,I2 as well as more recent studies on humans,s0 sug- 
gest that alternative physiological mechanisms are able to substitute for the nor- 
mal functions of the carbonic anhydrases. 
CARBONIC ANHYDRASE ACTIVITY IN CA I1 DEFICIENT 
ERYTHROCYTES 
The relative levels of the CA I, CA 11, and CA 111 isozymes in red cells from adult 
humans are approximately 85 : 13 : 1 re~pectively. '~ The specific C 0 2  hydrase ac- 
tivity/&, of human CA I1 at 37°C and pH 7.1, as determined by Wistrandsi (at 
physiological substrate concentrations) is about eight times higher than that of 
human CA I. No comparable activity data are available for human CA 111 at 37°C; 
however, as Sanyal et u I . ~ *  have shown, the specific COz hydrase activity (at pH 
7.5-7.6) of human CA 111 ( 10.5OC) is about 35 times lower than that of human CA I 
(13°C). Thus, we would expect very little contribution of CA 111 to the total 
carbonic anhydrase activity of human red cells. Because of the low specific activi- 
ties of the CA I and CA 111 isozymes, and the fact that they are probably substan- 
tially inhibited by chloride ions present in red cell ~ a t e r , ~ " ~  it is believed that 
these isozymes contribute only about 10% to the total carbonic anhydrase activity 
of the human red It should be pointed out, however, that in erythrocytes 
from CA 11-deficient individuals, the level of CA I appear to be slightly, but 
consistently, elevated, and the levels of CA 111 (which are normally about 90 times 
lower than CA I) were found by Carter et U I . ~ ~  to be doubled in erythrocytes of CA 
11-deficient individuals. 
TABLE 2. Carbonic Anhydrase Activity in Intact CA 11-Deficient and Control 
Erythrocytes 
Genotype 
Number of k,", ' [CO*I0 
Individuals 25°C 37°C 
CA II'/CA 11' (homozygote, normal) 2 320 t 62 (6) 314 2 87 (4) 
CA Il+/CA 11- (heterozygote) 4 232 2 57 (12) 
C A  11-/CA 11- (homozygote, deficient) 2 71 t lO(6) 173 * 36(14) 
, [CO,] is the original substrate concentration; k,.. formerly std k,,." Units (mean 2 SD) 
are M C 0 2  . sec-' M-' Hb,. Values in parentheses are number of assays performed. Intact 
red cells assayed in 24 mM NaHCO, (2% labeled with '*O). This corresponds to 1.987 mM 
C 0 2  at pH 7.2 which is the pH inside intact red cells in a pH 7.4 medium. The assay medium 
contained 0.125 M NaCl at pH 7.4. See references 17 and 55 for procedural details. 
Because the red cells of CA 11-deficient individuals appear to be functioning 
normally despite the fact that they are predicted to contain only about 10% of their 
normal carbonic anhydrase activity, we decided to determine the carbonic anhy- 
drase activity in intact CA 11-deficient red cells. These studies were carried out 
utilizing an exchange for determining carbonic anhydrase activ- 
ity within intact cells (S. J. Dodgson and R. E. Forster unpublished results). Fresh 
erythrocytes were obtained from several members of the CA 11-deficient family 
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from St. Louis.27 These included four obligate heterozygotes and two CA II- 
deficient homozygotes, and the results are shown in TABLE 2. As can be seen, the 
carbonic anhydrase activity in the red cells of the homozygous CA 11-deficient 
individuals increased from about 22% of those of the control values at 25°C to 
about 55% of controls at 37°C. If the results of this in uirro study reflect the actual 
conditions within the CA 11-deficient red cells in uiuo, then it seems reasonably 
clear why the respiratory function of carbonic anhydrase in these cells does not 
seem to be impaired under unstressed conditions. The possible compensatory 
mechanisms underlying these findings must await further study. However, one 
possible explanation is that in some way the inhibition of CA J by chloride is 
“relaxed” in the CA 11-deficient cells. 
SUMMARY 
Very little light has been shed on the role of the low-activity CA I isozyme in 
humans by studies on CA I-deficient individuals. On the other hand, CA II- 
deficient individuals exhibit abnormalities of bone, kidney and brain, implicating a 
functional role for the high-activity CA I1 isozyme in cells from these tissues and 
organs. It also appears that the CA 11-deficient red cell is capable of normal 
respiratory function under unstressed conditions. In addition, there is some pre- 
liminary evidence that those organs such as the eye which primarily contain the 
CA I1 isozyme, may be able to function effectively in the absence of CA 11. 
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